Heavy alcohol consumption linked to colorectal cancer

October 13, 2003

BALTIMORE (October 13, 2003)--Stony Brook University (Stony Brook, NY) researchers report that people who drink at least 9 glasses of alcoholic beverages made with distilled spirits per week for more than 10 years are much more likely than nondrinkers to develop colorectal cancer or premalignant polyps. They also note a protective effect for those who drink wine. The results, which will be presented at the 68th Annual Scientific Meeting of the American College of Gastroenterology, confirm the results of other studies.

Nearly 2,000 asymptomatic patients participated in the study. All had a screening colonoscopy, which uses a long, thin scope to examine the entire length of the colon. Cancer or suspicious polyps were found in the left colon of 6.1 percent of the nondrinkers and of 17.4 percent of those who drank at least 9 glasses per week of spirits for more than 10 years.

After adjusting for age, sex, family history, smoking, diet, weight, exercise, and educational level, the risk from heavy alcohol consumption remained.

"When screening for colorectal neoplasia, risk assessment is based on age and family history but not on facts such as behavior or lifestyle," said Gurvinder Sethi, M.D., of the Division of Gastroenterology and Hepatology at Stony Brook University. "Based on our data, we suggest that patients with significant spirits intake may benefit from more intensive CRC screening."
-end-
The ACG was formed in 1932 to advance the scientific study and medical treatment of disorders of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the needs of clinical gastroenterology practitioners. Consumers can get more information on GI diseases through the following ACG-sponsored programs:Contact:
Malaika Hilliard
202/973-5896
mhilliard@porternovelli.com

American College of Gastroenterology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.